Elucidation of the lymphatic pathway of periampullary and pancreatic body tumor using ICG fluorescence method

Elucidation of the lymphatic pathway of periampullary and pancreatic body tumor using fluorescence imaging

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs051240293

Enrollment

Registered

2025-03-13

Start date

2025-08-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periampullary and pancreatid body tumor periampullary and pancreatic body tumor

Interventions

Local injection of indocyanine green around tumor at the surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who are diagnosed periampullary and pancreatic body tumor and undergo pancreaticoduodenectomy by laparotomy 2) Written informed consent 3)Patients aged 18 years or older at the time of informed consent

Exclusion criteria

Exclusion criteria: 1) Allergic hypersensitivity of the indocyanine green 2)Patients with past history of gastrectomy 3)Patients who were judged inappropirate to participate this study by investigators

Design outcomes

Primary

Measure	Time frame
The visualization rate of lymphatic pathway for periampullary and pancreatic body tumor	—

Secondary

Measure	Time frame
1) Time required from ICC local injection to confirmation of lymphatic pathway 2) The presence or absence of histopathological metastasis in ICG fluoescence positive lymph nodes and their numbers 3) The visualization rate and differences of lymphatic pathways according to tumor location and type	—

Contacts

Public ContactKohei Nishio

Osaka Metropolitan University Graduate School of Medicine

m1155123@omu.ac.jp+81-6-6645-2121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026